Fitzgerald, Sean

Fitzgerald, Sean was paid $1.99M by Medicaid between Jan 2018 and Oct 2024, across 152 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 20% of everything it billed.

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Texas

Rank by total paid#5 of 97

Median peer was paid$24K

This provider vs. median85×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	36,362	$225K
2019	37,531	$214K
2020	27,993	$161K
2021	36,601	$452K
2022	47,088	$484K
2023	34,951	$268K
2024incomplete	37,308	$190K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	20%	7,141	5,829	$402K
80053	Comprehensive metabolic panel	6.5%	25,707	20,918	$130K
0202U	Oncology (prostate), multianalyte, gene expression profiling	5.8%	477	456	$116K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	4.9%	33,501	24,728	$97K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.5%	4,161	4,020	$90K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.5%	4,158	4,019	$90K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	3.5%	1,500	1,433	$69K
84443	Thyroid stimulating hormone (TSH)	2.7%	6,859	6,512	$54K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.4%	2,079	1,800	$49K
87086	Culture, bacterial; quantitative colony count, urine	2.0%	8,139	7,519	$41K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.9%	1,028	921	$38K
88305	Level IV - Surgical pathology, gross and microscopic examination	1.8%	1,105	984	$37K

140 more codes

0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	1.8%	474	$36K
80048	Basic metabolic panel (calcium, ionized)	1.7%	8,240	$35K
87480		1.6%	2,601	$32K
87510		1.6%	2,596	$32K
83735		1.4%	8,065	$28K
82803		1.3%	2,551	$26K
87040		1.2%	2,541	$25K
87641		1.2%	1,041	$23K
83605		1.2%	4,130	$23K
87660		1.1%	2,754	$22K
82962		1.0%	10,842	$20K
87081		<1%	6,090	$17K
84484		<1%	3,360	$16K
82330		<1%	1,835	$16K
80061	Lipid panel	<1%	4,677	$16K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	278	$15K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,047	$14K
87186		<1%	2,470	$14K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,801	$13K
85730		<1%	2,919	$12K
85610		<1%	5,626	$12K
86780		<1%	1,306	$11K
88341		<1%	214	$11K
83880		<1%	1,011	$11K
83036	Hemoglobin; glycosylated (A1C)	<1%	3,258	$10K
83690		<1%	2,964	$10K
86850		<1%	3,031	$9K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	688	$8K
81001		<1%	5,807	$8K
81025		<1%	4,101	$8K
80069		<1%	1,982	$8K
88342		<1%	527	$8K
84100		<1%	3,439	$8K
86901		<1%	3,295	$7K
84439		<1%	1,734	$7K
82607		<1%	1,224	$7K
88307		<1%	102	$7K
88189		<1%	117	$7K
87581		<1%	280	$6K
86140		<1%	2,824	$6K
86803		<1%	822	$6K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	281	$6K
82728		<1%	1,572	$6K
84466		<1%	1,414	$6K
87486		<1%	264	$6K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	277	$6K
86900		<1%	3,279	$6K
87088		<1%	1,033	$6K
80202		<1%	735	$5K
85384		<1%	1,634	$5K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	186	$5K
87070		<1%	1,432	$5K
83970		<1%	295	$4K
82784		<1%	589	$4K
87147		<1%	2,527	$4K
82570		<1%	1,766	$4K
85379		<1%	1,117	$4K
83540		<1%	1,314	$4K
81003		<1%	3,557	$4K
85027		<1%	1,304	$4K
84702		<1%	830	$4K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	481	$4K
82550		<1%	1,119	$4K
87340		<1%	549	$3K
86003		<1%	117	$3K
82746		<1%	533	$3K
85014		<1%	2,225	$3K
83615		<1%	919	$3K
83516		<1%	417	$2K
82805		<1%	91	$2K
86038		<1%	295	$2K
85652		<1%	1,672	$2K
87077		<1%	516	$2K
87205		<1%	953	$2K
80047		<1%	397	$2K
84703		<1%	512	$2K
82565		<1%	793	$2K
82043		<1%	905	$2K
84550		<1%	759	$2K
80076		<1%	424	$1K
86920		<1%	324	$1K
86762		<1%	298	$1K
85018		<1%	1,238	$1K
87493		<1%	57	$1K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	147	$1K
80074		<1%	72	$1K
83655		<1%	207	$1K
84478		<1%	483	$1K
84132		<1%	472	$1K
84156		<1%	814	$909.59
87075		<1%	133	$907.03
84295		<1%	451	$889.77
82248		<1%	432	$853.93
85045		<1%	608	$772.60
87522	Neg quan hep c or qual rna	<1%	27	$754.65
84481		<1%	159	$754.48
84146		<1%	107	$704.55
82785		<1%	134	$644.52
86480		<1%	28	$636.30
87807		<1%	127	$634.75
87536		<1%	14	$608.30
82247		<1%	225	$549.77
82951		<1%	85	$533.63
82947		<1%	299	$458.85
88304		<1%	29	$429.88
82140		<1%	99	$425.72
86360		<1%	27	$380.43
84403		<1%	33	$372.88
84480		<1%	69	$362.52
86706		<1%	52	$358.40
85576		<1%	16	$346.04
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	27	$308.74
86359		<1%	26	$294.32
85347		<1%	106	$276.13
80164		<1%	59	$264.84
87102		<1%	48	$251.10
88141		<1%	27	$238.55
80306		<1%	34	$203.77
84145		<1%	13	$192.98
87899		<1%	15	$148.20
85049		<1%	114	$141.37
86880		<1%	39	$139.20
82077		<1%	13	$134.68
87184		<1%	26	$117.00
80177		<1%	25	$115.39
82533		<1%	13	$100.65
87210		<1%	28	$96.35
87427		<1%	15	$93.75
84300		<1%	46	$93.28
87045		<1%	15	$92.25
86431		<1%	27	$78.84
86308		<1%	30	$66.00
81015		<1%	57	$65.50
82950		<1%	26	$60.58
83020		<1%	12	$51.72
82272		<1%	54	$50.58
82009		<1%	31	$34.02
86592		<1%	13	$26.00
89050		<1%	12	$22.75
87046		<1%	15	$18.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.